The High Technology Investment Plan (Inveat) for the National Health System aims to improve people’s quality of life by diagnosing diseases at early stages, enabling rapid therapeutic intervention. INVEAT also pays special attention to the pathologies with the greatest impact on the National Health System (SNS), particularly those related to neurological, oncological, and rare diseases.

This investment will improve the level of technological obsolescence of the equipment installed within the SNS, as well as the equipment density rate per 100,000 inhabitants.

Over the next two years, the investment plan will provide for the technological renewal of 100% of equipment that is 12 years old or more. In addition, linear accelerators and CT scanners that are 10-11 years old (585 units) will be renewed. All of this is in line with the recommendations of scientific societies.

Here is how the first €398.8 million to renew the SNS’s high-technology equipment will be distributed by autonomous community:

    •       Andalusia: €75,965,100 (19.04% of the total)

    •       Aragon: €13,136,973 (3.29%)

    •       Asturias: €6,941,650 (1.74%)

    •       Balearic Islands: €8,667,580 (2.17%)

    •       Canary Islands: €20,776,533 (5.21%)

    •       Cantabria: €7,953,218 (1.99%)

    •       Castilla-La Mancha: €13,955,383 (3.50%)

    •       Castile and León: €20,105,407 (5.04%)

    •       Catalonia: €50,739,894 (12.72%)

    •       Valencian Community: €43,750,524 (10.96%)

    •       Extremadura: €9,322,545 (2.34%)

    •       Galicia: €27,318,315 (6.85%)

    •       La Rioja: €4,205,342 (1.05%)

    •       Madrid: €57,731,416 (14.47%)

    •       Murcia: €13,599,732 (3.41%)

    •       Navarre: €8,268,645 (2.07%)

    •       Basque Country: €16,554,846 (4.15%)

    •       According to the document, the Ministry of Health will reserve €1,004,690 to acquire high-technology equipment through Ingesa.